Thinking of joining a study?

Register your interest

NCT04439474 | COMPLETED | Diabetes Mellitus, Type 2


Determining the Effect of Vitamin D, Dyslipidemia and Microvascular in Patients With Type 2 Diabetes
Sponsor:

Baqiyatallah Medical Sciences University

Information provided by (Responsible Party):

Mohammad Sadeh Bagheri Baghdhna

Brief Summary:

This study looked at the effect of vitamin D levels on the complications of type 2 diabetes and the fat profile of patients with diabetes.Participants in this study were divided into two groups. One group included participants with vitamin D deficiency and the other group did not.The first group receives 50,000 units of oral vitamin D 3 daily for up to 8 days.

Condition or disease

Diabetes Mellitus, Type 2

Intervention/treatment

Vitamin D3

Routine treatment

Phase

NA

Study Type : INTERVENTIONAL
Estimated Enrollment : 187 participants
Masking : NONE
Primary Purpose : TREATMENT
Official Title : Determining the Effect of Vitamin D, Dyslipidemia and Microvascular in Patients With Type 2 Diabetes
Actual Study Start Date : 2018-10-10
Estimated Primary Completion Date : 2019-11-10
Estimated Study Completion Date : 2020-02-10

Information not available for Arms and Intervention/treatment

Ages Eligible for Study:
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * Patients with type 2 diabetes
  • * Having conscious satisfaction
Exclusion Criteria
  • * Patients with a history of gastrointestinal surgery
  • * Patients with a history of renal failure
  • * Patients with a history of vitamin D intake and calcium-containing compounds
  • * Patients with a history of liver disease

Determining the Effect of Vitamin D, Dyslipidemia and Microvascular in Patients With Type 2 Diabetes

Location Details

NCT04439474


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


Not yet recruiting

Iran, Islamic Republic of,

Mohammad Sadeh Bagheri Baghdhna

Tehran, Iran, Islamic Republic of, 0

Loading...